Literature DB >> 23759203

Quetiapine and flupentixol differentially improve anterior cingulate cortex function in schizophrenia patients: an event-related potential study.

Sabrina Schneider1, Thomas Juergen Bahmer, Florian Gerhard Metzger, Andreas Reif, Thomas Polak, Bruno Pfuhlmann, Gudrun Walter, Mark-Christian Eberle, Lena Helene Ernst, Andreas Jochen Fallgatter, Ann-Christine Ehlis.   

Abstract

Atypical antipsychotic agents are a frequently and effectively used treatment in schizophrenia and psychotic disorders. Other than conventional antipsychotics, which mainly exert their pharmacological effect in subcortical dopaminergic systems, atypical antipsychotics additionally affect partly serotonergically innervated structures within prefrontal areas, such as the anterior cingulate cortex (ACC). However, only few controlled, randomized studies have so far investigated direct and indirect effects of atypical antipsychotics on the ACC and, up until now, no clinical investigation has exclusively addressed the specific effects of quetiapine on ACC function. The present study assessed ACC function in 18 quetiapine-medicated patients and 13 flupentixol-treated patients suffering from schizophrenia by means of the error-related negativity (ERN), a neurophysiological marker of ACC function, in a pre-post design. Between-group comparisons revealed different effects of quetiapine and flupentixol on ACC function despite similar improvement in psychopathology, cognitive performance and quality of life. Whereas atypical treatment was associated with an increase in amplitudes over time, there were prolonged ERN peak latencies in patients treated with the typical agent. Moreover, treatment effects depended on baseline prefrontal cortex function in both groups. We conclude that both flupentixol and quetiapine improve prefrontal function especially in patients with weak initial ACC function which might be due to their shared affinity for serotonin receptors in frontal brain regions. However, since this affinity is more pronounced for quetiapine, patients treated with quetiapine seemed to profit more evidently concerning their prefrontal cortex function compared to patients of the flupentixol group, who exhibited a compensatory prolongation of processes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23759203     DOI: 10.1017/S1461145713000540

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  4 in total

1.  Performance monitoring and post-error adjustments in adults with attention-deficit/hyperactivity disorder: an EEG analysis.

Authors:  Ann-Christine Ehlis; Saskia Deppermann; Andreas J Fallgatter
Journal:  J Psychiatry Neurosci       Date:  2018-07-31       Impact factor: 6.186

2.  Integrating frequency and magnitude information in decision-making in schizophrenia: An account of patient performance on the Iowa Gambling Task.

Authors:  Elliot C Brown; Samantha M Hack; James M Gold; William T Carpenter; Bernard A Fischer; Kristen P Prentice; James A Waltz
Journal:  J Psychiatr Res       Date:  2015-04-28       Impact factor: 4.791

3.  Performance monitoring and post-error adjustments in adults with attention-deficit/hyperactivity disorder: an EEG analysis

Authors:  Ann-Christine Ehlis; Saskia Deppermann; Andreas J. Fallgatter
Journal:  J Psychiatry Neurosci       Date:  2018-11-01       Impact factor: 6.186

4.  Neural oscillatory responses to performance monitoring differ between high- and low-impulsive individuals, but are unaffected by TMS.

Authors:  Beatrix Barth; Tim Rohe; Saskia Deppermann; Andreas Jochen Fallgatter; Ann-Christine Ehlis
Journal:  Hum Brain Mapp       Date:  2021-02-19       Impact factor: 5.038

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.